EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

In connection with the accompanying Quarterly Report on Form 10-QSB of
BrainStorm Cell Therapeutics Inc. for the period ended September 30, 2005, the
undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my
knowledge and belief, that:

(1) such Quarterly Report on Form 10-QSB for the period ended September 30, 2005
fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and

(2) the information contained in such Quarterly Report on Form 10-QSB for the
period ended September 30, 2005 fairly presents, in all material respects, the
financial condition and results of operations.



       November 21, 2005              /s/ David Stolick
                                         -----------------------------------
                                         Name: David Stolick
                                         Title: Chief Financial Officer
                                               (Principal Financial Officer)

A signed original of this statement required by Section 906 has been provided to
the registrant and will be retained by the registrant and furnished to the
Securities and Exchange Commission or its staff upon request.